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In recent years, stimuli responsive polymer based gene delivery vehicle design for cancer treatment
and treatment of other genetic disorders has received extensive attention. Early studies focusing on
DNA delivery have been facilitated by functional polymers and this area has seen further growth
spurred by recent gene silencing strategies developed for small RNA [i.e., small interfering RNA
(siRNA) or micro RNA (miRNA)] delivery. DNA and small RNAs possess analogous properties;
however, their explicit differences define the specific challenges associated with the delivery route
and the design of functional materials to overcome distinct challenges. Apart from classical gene
delivery, the recent advances in genome editing have revealed the necessity of new delivery devices
for genome editing tools. A system involving CRISPR (clustered, regularly interspaced, short
palindromic repeats) and an endonuclease CRISPR-associated protein 9 (Cas9) coupled with
a short, single-guide RNA (sgRNA) has emerged as a promising tool for genome editing along with
functional delivery systems. For all these nucleic acid based treatments, the internal or external
physiochemical changes in the biological tissue/cells play a major role in the design of stimuli
responsive delivery materials for both in vitro and in vivo applications. This review emphasizes the
recent advances in the use of pH, temperature, and redox potential-responsive polymers overcoming
hurdles for delivery of gene and gene editing tools for both in vitro and in vivo applications.
Specifically the chapter focuses on recently proposed delivery strategies, types of delivery systems,
and polymer synthesis/modification methods. The recent advances in CRISPR/Cas9-sgRNA
technology and delivery are also described in a separate section. The review ends with current
clinical trials, concluding remarks, and future perspectives.
I. INTRODUCTION
Gene delivery has been considered a promising tool for
the treatment of cancer for more than a decade. During
this period, various obstacles for gene delivery and their
potential solutions have been investigated with the de-
velopment in technology. The challenges such as limited
gene transfer efficiency, targeting to specific cells and
tissues, safety etc., have been addressed by strategies
based on viral and nonviral vectors.1–3 The concerns in
using engineered viral vectors such as biosafety, cost of
production, nonspecific interactions, and loading capac-
ity, have limited their clinical application and pushed the
roadmap of research to safer nonviral vector alternatives,
mainly based on polymers.3–5 Unlike viruses, which have
naturally evolved to internalize into the host, the nonviral
vectors face multiple extracellular and intracellular barriers
such as adhesion on the cell surface, cellular entry, escape
from the endosome, and release of the nucleic acids into
their intracellular target sites, to safely deliver the cargo.6–9
These challenges have encouraged the development of
internal/external stimuli responsive smart polymers, which
represent an exciting and rapidly growing area of polymer
science.10–12
The designed stimuli responsive polymers have been
capable of undergoing reversible macroscopic changes by
transforming their physicochemical properties in response
to various endogenous (pH, redox potential, enzyme con-
centration etc.) or exogenous (temperature, light etc.)
stimuli.10–14 The major distinguishing feature of these
smart polymeric systems is the temporal and spatial
controllability allowing for minimizing side effects by
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site-specific therapy. The desired properties of a smart
polymeric multifunctional delivery system such as confor-
mation, hydrophilicity/hydrophobicity, surface charge etc.
can be controlled by varying the copolymer architecture
(monomer sequence, length, composition etc.), overall
molecular weight and chemistry of functional groups.
The attachment of stimuli-responsive moieties to copoly-
mer architectures using functional monomers or linkers
make it possible to trigger assembly/disassembly via bond
cleavage or conformational, hydrophilicity/hydrophobicity,
surface charge or solubility changes, depending on the
stimulus and the type of chemistry.15–17 Therefore, cel-
lular uptake, endosomal escape, intracellular targeted
payload release, and overall gene delivery efficiency of
nonviral vectors have been enhanced by stimuli respon-
sive polymers.11,17
This review overviews the recent advances in the use
of responsive polymers to overcome the key hurdles
facing nucleic acid delivery for in vitro and in vivo
applications. The review mentions the stimuli responsive
strategies using various polymer combinations that can be
applied for the delivery of all types of nucleic acids such
as DNA, siRNA, or miRNA despite their structural dif-
ferences. At the beginning, the current challenges and
problems (such as, stability, cellular entry, endosomal
escape, cell/organelle specific targeting etc.) of gene
delivery (including DNA, siRNA, and miRNA) and
necessity of responsive polymers to solve these problems
are outlined. Then, the review specifically focuses on pH,
temperature and redox potential stimuli-triggered mono,
dual or multi responsive polymer based gene delivery
systems and strategies for in vitro and in vivo applications.
In addition, different polymer synthesis/modification
methods are reviewed and literature findings regarding
the stimuli responsive properties (pH, temperature, and
redox potential) and the performance of the polymers to
overcome the outlined delivery challenges are discussed.
A separate subsection based on the delivery of gene
editing tools such as the CRISPR-Cas9-sgRNA system is
also discussed. The chapter ends with mentioning current
clinical trials, concluding remarks, and future perspectives.
II. BARRIERS FOR NON-VIRAL GENE DELIVERY
The success of nonviral gene therapy completely depends
on the ability of the vector system in overcoming the
several critical intracellular and extracellular barriers and,
thus, achieving high delivery efficiency. These barriers
include effective circulation in blood, diffusion through
the extracellular matrix, stability and protection from
enzymatic degradation, cellular association and uptake,
endosomal escape, unpacking of the vector system, and
release of the nucleic acid cargo in the cytoplasm or in
nucleus (Fig. 1).18–22 Failure at any of these steps signif-
icantly reduces the delivery and transfection efficiency.
Nucleic acids (DNA or small RNAs), which are
double-stranded, negatively charged, and hydrophilic
bio-macromolecules in nature, have difficulties in cross-
ing the cellular membranes in their naked form and are
subject to enzymatic degradation by the endogenous
nucleases upon the cellular entry.20,23 In traditional
approaches, the cationic polymers are electrostatically
complexed with negatively charged nucleic acids forming
polyplexes to prevent enzymatic degradation and serum
protein induced dissociation, which may possibly result
in premature release, extracellular degradation, and poor
cellular uptake of nucleic acids.24–28 The dense and stable
polyplexes are desired for nuclease and serum stability
concerns; however, electrostatically weaker complexation
is needed at the target site to provide unpacking of the
polyplexes and the subsequent release of free nucleic
acid.24–28 In addition, these vectors should be capable of
avoiding immune response, nonspecific interactions with
blood components and nonspecific uptake by reticuloen-
dothelial system (RES), and be transported into the target
tissue or cells. Transport of macromolecules and nucleic
acid carrier systems is far easier across the tumor
endothelium than that of the normal endothelium due to
their leaky and discontinuous vascular structures. While
this situation allows permeation, the poor lymphatic
drainage leads to poor retention in the tumor tissue.
The EPR effect can be enhanced by providing surface
modification or using stimuli responsive polymers;
therefore, the vectors escaping from RES are able to
target tumor sites through EPR effect. Because of this,
during the circulation in blood, a vector with neutral
and hydrophilic corona is preferred to prevent nonspecific
interactions; however, this protective corona inhibits effi-
cient cellular uptake and endosomal escape properties.29,30
Therefore, these contradictory requirements can be solved
by the use of stimuli responsive vectors.
The stable nonviral vectors are uptaken by cells usually
via endocytosis or a different mechanism depending
on the vector chemistry.31,32 However, it is crucial to
provide cell/organelle specific targeting to avoid random
interactions which may possibly lead to undesired
mutations.33,34 Following the association with the target
FIG. 1. Barriers for gene (DNA or small RNAs) delivery.
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cell and cellular internalization, the risk of vector/nucleic
acid complex degradation through acidic pH and acid
activated enzymes in the endosome/lysosome exists.
The endosomal compartments of cells are significantly
more acidic (pH 5.0–6.2) than the cytosol or intracellular
space (pH 7.4) in the early endosomal stage due to the
ATP-mediated proton accumulation. Following the early
endosome, the endosomal content is then gradually
acidified (pH 4.5) to the lysosomes and contains various
nucleases that induce the degradation of nucleic acids.35
The ability of escaping from the low pH and endosomal
digestive processes while avoiding premature decomplex-
ation is the most critical step to be overcome by the vector.
Proton sponge effect is a commonly used strategy in
designing polymer based nonviral vectors with the ability
of efficient endosomal escape. Through the proton sponge
mechanism, the protonation of amine groups in cationic
polymers destabilizes the endosomal membrane and sub-
sequent inflow of ions and water leads to rupture of the
endosomal membrane and cytosolic release of the entrapped
components. As an example, tertiary amine groups’ hydro-
phobic chains accumulate in endosomes and upon pro-
tonation, and they cause disruption of the membrane.35,36
Following endosomal escape, intracellular targeting
determines the overall gene delivery efficiency. The
targeted release site of nucleic acids varies depending
on the nucleic acid type. For example, plasmid DNA
must be localized in the nucleus, where gene expression
is initiated by transcription, whereas siRNA or miRNA
acts in the cytoplasm, where it targets the homologous
messenger RNA (mRNA).20,23 Therefore, the vector
systems designed for DNA delivery should be further
directed to the nucleus, while the endosomal escape and
cytoplasmic release should be sufficient for the vectors
designed for siRNA or miRNA delivery. However,
reaching the cytoplasm or nucleus does not ensure the
success of the system unless the vector efficiently releases
its cargo and shows activity. As mentioned earlier, the
vector should not only protect the loaded nucleic acid on
the way to nucleus or cytoplasm, but also provide an
efficient dissociation and release on the site of action to
achieve a successful activity and functional delivery.
Overall, the key to designing effective nonviral gene
carriers to overcome the external and internal hurdles
lies in the analysis of biological response and physico-
chemical characteristics of the living tissues/cells. Thus,
the extra and intracellular environments can be used as
biological triggers to develop stimuli responsive polymer
based gene delivery vectors.
III. BIOLOGICAL STIMULI RESPONSIVE
POLYMERIC DESIGNS
Many different physiochemical/biological changes
occur in healthy or diseased tissues/cells during their
regular life cycle. These changes, mostly involving pH,
temperature and redox potential, can be used to manipulate
the properties and efficiency of gene delivery systems.
For instance, a conventional multifunctional polymeric
vector design involves cationic segments or cleavable
chemical conjugation sites for condensing/attaching nucleic
acids, temperature responsive hydrophilic segments for
enhancing stability, cellular entry, and biocompatibility
via steric shielding and pH responsive segments providing
endosomal escape.3,10–13,17 Therefore, block copolymer
systems allowing the incorporation of multiple function-
alities into a single polymer structure have been declared
as promising candidates for gene delivery applications.
There are two widely-used approaches to synthesize
these responsive polymers: reversible addition fragmen-
tation chain transfer (RAFT) and atomic transfer radical
polymerization (ATRP), which enable control over the
polymer architecture, molecular weight, molecular weight
distribution, functionality, and composition. RAFT poly-
merization allows for the design of macromolecules with
complex architectures including block, graft, comb, and
star structures with predetermined features. In RAFT chain
transfer agents, such as thiocarbonylthio compounds,
mediate the polymerization via a reversible chain-transfer
process. The advantage of RAFT polymerization involves
the use of various solvents, wide temperature ranges, high
functional group tolerance, and absence of a metal catalyst.
However, the specificity of particular RAFT agents for
a limited set of monomers and requisition of multistep
procedure and subsequent purification for synthesis is the
main drawback of RAFT. Moreover, the gradual decom-
position of the dithioester moiety in unstable RAFT agents
yield small sulfur compounds and pungent odor.37,38
Although the presence of sulfur moieties and color in the
resulting polymer may be undesirable, this can be elimi-
nated with further chemical and physical purification steps.
As an alternative to RAFT, ATRP has been widely used
in the research holding the most citations in the literature
in preparation of polymers with precisely controlled
molecular weight, narrow molecular weight distribution,
and high degree of chain end functionalities, topologies,
and compositions. ATRP is much more tolerant of func-
tional groups than ionic polymerizations resulting in facile
introduction of various functionalities into the polymer
structure. The use of functional initiators or substitution of
the terminal halogen atom provides end-functionalized
polymers whereas the direct polymerization of functional
monomers or polymerization of protected monomers
followed by post-polymerization chemical transforma-
tions yields polymers with multiple functionalities along
the backbone. ATRP uses simple initiators, mainly alkyl
halides containing one or more halogen atoms. The archi-
tecture of the prepared polymers can be varied from linear
(alkyl halides with a single halogen atom), to star-like
or brush-like (multiple halogen atoms in the initiator)
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depending on the initiator structure and the number of
halogen atoms.39,40 One drawback of the classical ATRP
method is the use of large amounts of the CuX/ligand
catalyst complex, which require tedious purification.
Nevertheless, both ATRP and RAFT are the most widely
used methods to synthesize the stimuli responsive
multifunctional polymers intended for gene delivery
applications. This section overviews polymer based stimuli
responsive nonviral vectors developed to effectively
address the extra and intracellular barriers by responding
to pH, temperature, and redox potential dependent
biological stimuli.
A. pH responsive designs
pH changes in extracellular or intracellular environ-
ments play a critical role in the design of functional gene
delivery vectors. Different from the normal tissue, the
extracellular pH in cancer tissues varies around pH 6–7,
which makes pH-responsiveness an important tool to
target tumors with chemotherapeutics. On the other hand,
in intracellular environments, the pH values vary from 5–6
in early endosome to 4–5 in late endosome/lysosome,
which can be used as an efficient tool to provide endo-
somal membrane disruption. These extra and intracellular
pH gradients can be used to design gene delivery vectors
that facilitate selective targeting and endosomal escape.
There are also differences in endosomal pH of cancer and
noncancer cells, which we have exploited in Zhang et al.41
Several strategies/chemistries have been identified for
the design of pH-responsive copolymer assemblies for
delivery of nucleic acids (DNA or small RNAs), such as
the formation of polymer–peptide conjugates, introduc-
tion of acid-labile functional groups to the copolymer
backbone or along the copolymer chain, or use of pH-
triggered bond cleavage or conformational change
disrupting the hydrophobic/hydrophilic balance or
degrading the copolymer. The chemistry coupled with
the controlled self-assembly of copolymers and their
responses to pH changes can be manipulated through
changing the balance between the blocks with differ-
ent features (hydrophobic/hydrophilic balance, electro-
static interactions, block length, molecular weight etc.)
or adding some active groups to create effective conju-
gation sites in the structure.42–51
Among these strategies, polymer–peptide conjugates are
an attractive class of materials that undergo pH-dependent
conformational changes. The pH-dependent changes in
these conjugates mainly depend on the transformation
ability of polypeptide secondary structure from random
coil to a-helix, which manipulates the changes in the chain
configuration facilitating cellular entry and endosomal
escape and targeting issues.52–57 However, fusogenic
peptides alone are not good enough to complex/interact
with negatively charged nucleic acids, restricting their
co-localization with nucleic acids, which is important for
endosomalytic release. Thus, due to a lack of interactions,
the peptide itself may escape from the endosome without
causing serious damage in the endosomal membrane and
leaving nucleic acids in the endosome. These drawbacks
of fusogenic peptides led to their use in combination
with cell penetrating peptides or cationic polymers.58
Nevertheless, in these cases, the rapid elimination of
polymers modified by fusogenic peptides during the
blood circulation were observed in some in vivo studies
addressing further optimization and the use of shorter
peptide moieties.59–61
The conjugation of drug/nucleic acid molecules to
copolymer structures via acid-labile linkers has been
proposed as another strategy. Covalent attachment of
drug/nucleic acids to carriers provides different potential
benefits including stability, enhanced circulation times,
targeted cellular uptake, endosomal escape, and promoted
release. These chemistries used in copolymer assemblies
include acid-labile hydrazine,62,63 carbamate,62 catechol,64
and Schiff base,65 which simply take advantage of the
acidic conditions in the lysozyme to release the cargo
without enzymatic degradation. However, the selection of
the linker changes depending on the specific chemical
groups (i.e., therapeutics must have suitable ketone and
aldehyde moieties to form hydrazine), cancer, and active
agent type. This specificity brings about the nonuniversal
use of linkers. In addition, possible cleavage of linkers
at physiological pH causes premature release and the
fragmented parts of polymer backbone or linker may
cause undesired nonspecific interactions.66
As an alternative, the vector systems based on pH
responsive polymers and their derivatives have been
garnering attention. The proton sponge is considered as
the main endosomal escape mechanism which relies on
the use of materials possessing high buffering capacity
and swelling property when protonated. The rupture of
the endosomal membrane and release of the entrapped
components occur upon the protonation induced inflow
of ions and water into the endosomal environment.
Tertiary amine groups with a hydrophobic chain in the
polymer structure have been shown as the main compo-
nent to accumulate in acidic endosomes resulting in
disruption of the membrane upon protonation.35 In the
work of Convertine et al., a modular design of diblock
polymer that combines the siRNA condensing ability
of positively-charged dimethyl aminoethyl methacry-
late (DMAEMA) block and the pH-responsive endo-
somal releasing block composed of DMAEMA and
propylacrylic acid (PAA), together with butyl methacy-
late (BMA) was developed using reversible RAFT poly-
merization technique. This technique enables precise
control over molecular weight polydispersities and
eliminates the need for stringent reaction conditions.
The membrane disruption was mediated by the
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hydrophilic-to-hydrophobic transition of PAA, which was
induced by the gradual protonation of carboxylic acid
residues along the polymer backbone at endosomal pH.
The boosting effect of increased hydrophobicity in nucleic
acid delivery has been demonstrated in previous works;
however, after a certain point this may lead to a possible
phase-separation eliminating carrier properties. There-
fore, a tradeoff still exists with solubility and efficacy.
Moreover, although the protonation of carboxylic acid
residues triggers the membrane disruption process, their
negative charges cause electrostatic repulsion affecting
the nucleic acid loading and stability of complexes.
Their overall in vitro results emphasize that variation of
the ratios of different polymer blocks and polymer/siRNA
charge ratio exhibits a great control over the pH-
dependent endosomal escape and the cellular uptake.
The endosomal escape property can be controlled with
the molecular weight of the polymer; however, it should
remain below 45–50 kDa which is the limit for renal
clearance. Although the possible adverse effects of
electrostatic complexation of nucleic acids with posi-
tively charged polymers (such as excessive cationic
charge, toxicity, poor nucleic acid release etc.) have
already been known, it is possible to achieve efficient
activity at certain ratios. The positively charged com-
plexes are open to nonspecific protein adsorption and
showed poor stability in in vivo applications; however, at
certain ratios the surface charge of the polyplexes were
found to be very close to neutral, which prevents unde-
sired protein adsorption and enhance circulation time.43
Beside these tradeoffs, the vector design strategy also
changes depending on the type of the nucleic acid, order,
and length of the polymer blocks.67 In our previous work,
which will be described in greater detail in the following
sections, we were able to use pentablock copolymers
providing a pH-responsive proton sponge effect for the in
vitro delivery of both DNA and siRNA.68–71
In some cases, the block copolymers need further
modification in combination with other strategies to
enhance its properties through different architectures.
For example, Lin et al. designed degradable, pH-sensitive,
membrane destabilizing, and comb-like diblock polymers.
The first block involves a copolymer of pH-sensitive
ethyl acrylic acid (EAA) monomers and hydrophobic
butyl methacrylate (BMA) or hexyl methacrylate mono-
mers, while the second block is a homopolymer of
N-acryloxy succinimide (NASI) or ß-benzyl L-aspartate
N-carboxy-anhydride (BLA-NCA) monomers. The sec-
ond block was functionalized by acid-labile hydrazone
linkages to provide controlled grafting of hydrophobic
hexyl methacrylate (HMA) and cationic trimethyl
aminoethyl methacrylate (TMAEMA) copolymers. These
polymers were electrostatically complexed with siRNA to
form pH-sensitive particles. The membrane-destabilizing
backbone and the hydrophobic monomers embedded
in the comb-like grafts synergistically disrupt the
endosomal membrane and release the nucleic acid
cargo providing advantage over the existing systems.
These comb-like polymers with a molecular weight below
45–50 kDa can degrade into smaller fragments in acidic
environment minimizing their toxicity and facilitating
the in vivo renal excretion.72
In another study, Synatschke et al. investigated the
effect of the number of arms and molecular weights of
star shaped PDMAEMAs on in vitro transfection effi-
ciency of DNA. Their results indicate that the minimum
possible molecular weight and branched architecture are
the keys for successful transfection.73 Similar strategies
using different polymer architectures were also used for
miRNA delivery. Qian et al. reported amphiphilic star-
branched copolymers comprising of polylactic acid
(PLA) and polydimethylaminoethyl methacrylate
(PDMAEMA) with different molecular architectures for
combined delivery of doxorubicin and miR-21i (Fig. 2).
They obtained various polymer architectures by a combi-
nation of ring-opening polymerization, atom transfer
radical polymerization (ATRP), and click chemistry via
an “arm-first” approach. Their polymers are capable of
forming nano-sized micellar structures and the in vitro
and in vivo results suggest that the gene transfection
efficiency and tumor inhibition ability show a remarkable
dependence on their molecular architecture.74
It is known that the presence of hydrophilic blocks
in the delivery systems may enhance stability and blood
circulation; however, they may also inhibit the cellular
uptake. Similarly, the electrostatic complexes of polymers
and nucleic acids having net positive charge show good
stability and promote cellular uptake, whereas the exces-
sive positive charge may cause severe toxicity and inhibit
gene release. The introduction of micelles in the polymer
structure has been shown to provide benefit in solving
these issues and induce cellular uptake. For instance,
Convertine et al. enhanced their previously described
diblock copolymer siRNA carriers, composed of BMA,
PAA, and DMAEMA blocks, by inducing their micelle
formation ability through the incorporation of a longer
endosomolytic block with increased hydrophobic con-
tent. They obtained siRNA loadings through electrostatic
interactions and found out that the siRNA binding to the
cationic shell block does not perturb micelle stability.
The presence of micelles trigger the cellular uptake of
the systems by 3-fold, and therefore showed enhanced
mRNA knockdown in vitro.75 In another work, Ripoll
et al. designed novel pH-responsive photopolymerized
diacetylenic amphiphile (PDA) micelles for the intra-
cellular delivery of siRNAs (Fig. 3). In their design, the
hydrophilic histidine head-group provided improved
in vitro siRNA delivery by allowing the endosomal
escape via imidazole protonation without showing severe
toxicity.76
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As a different strategy, Lin et al. used pH responsive
micellization of star shaped polymers for the in vitro
combined delivery of imiquimod and plasmid DNA.
They developed dual functional unimolecular micelles
based on a pH-responsive amphiphilic star polymer
(PLA-b-PDMAEMA-b-PEtOxMA) through combined
electron-transfer atom-transfer radical polymerization and
ring-opening polymerization. Their results show efficient
pH dependent delivery through pH-responsive unimo-
lecular micelles.77
Micellization strategy was also used for miRNA delivery.
In the work of Kumar et al., they used methoxy
poly(ethylene glycol)-blockpoly(2-methyl-2-carboxyl-
propylenecarbonate-graft-dodecanol-graft-tetraethylene-
pentamine) (mPEG-b-PCC-g-DC-g-TEPA) polymers to
coformulate miR-let7b and GDC-0449 into micelles for
both in vitro and in vivo delivery. Their copolymer self-
assembled into micelles and encapsulated hydrophobic
GDC-0449 into its core, while allowing complex forma-
tion between miR-let7b and its cationic pendant chains.
Their results show decreased tumor cell proliferation with
increased apoptosis in the in vivo experiments.78
The presence of micelles can also be used to trigger
the release of membrane destabilizing agents. Yu et al.
FIG. 2. Synthesis of star-branched PLA-PDMAEMA block copolymers. Reproduced with permission from Elsevier.74
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reported amphotericin B (AmB) loaded, dual pH-
responsive micelleplexes, which were self-assembled from
poly[2-(dimethylamino) ethyl methacrylate]-block-poly[2-
(diisopropylamino)ethyl methacrylate] (PDMA-b-PDPA)
diblock copolymers, for in vitro siRNA delivery. The
micelleplexes were formed by loading AmB into the
hydrophobic PDPA core, and complexing siRNA with
a positively charged PDMA shell. They hypothesized
that the PDMA-b-PDPA/siRNA micelleplexes can disso-
ciate in early endosomes and release endosomal mem-
brane destabilizing AmB to significantly increase siRNA
activity.79
The main problem with the electrostatically formed
polyplexes is the poor release of nucleic acids due to the
strong electrostatic interactions. Thus, the pH responsive
polymeric micelles are also used to facilitate the release
of nucleic acids. The protonation of the hydrophobic inner
part of the micelle causing a pH triggered disassembly,
endosomal membrane disruption, and subsequent release
of the cargo is considered as a common strategy. Such a
behavior was achieved previously with a poly(L-histidine)-
b-PEG (PHis-b-PEG) and poly(L-lactic acid)-b-PEG-b-
polyHis-ligand (PLLA-b-PEG-b-PHis-ligand) bearing
different targeting moieties.80,81
Stimuli response to pH can also be used for reversible
shielding or masking strategies developed through
dynamic covalent linkages or noncovalent interaction.15
The modifications with neutral hydrophilic polymers,
such as PEG, provide stability and prolonged circulation
in blood. However, they cause poor transfection efficacy
due to inefficient cellular uptake and/or endosomal
escape.50,82 In addition, some cationic fusogenic peptides
and synthetic endosomolytic polymers were found to
be cytotoxic due to their excessive positive charge
and strong interaction with plasma membranes.26,83–85
Therefore, pH-sensitive responsible polymers and related
chemistries can also be used to solve these issues. The
use of acid labile block copolymers with hydrazone,86
acetal,87 cyclic orthoester linkers88 unmasked the polymer
backbone at the endosomal pH and induced membrane-
disruptive properties and cytoplasmic delivery of the
therapeutic agents upon the endocytosis. With a similar
strategy, Rozema et al. reported polyconjugates based on
an amphipathic membrane disruptive poly(vinyl ether)
(PBAVE) backbone in which oligo PEG (as a shielding
agent) and N-acetylgalactosamine (targeting ligand) were
attached through acid labile maleamate linkages. The
advantage of this system over the above mentioned
systems is the siRNA attachment through cleavable
disulfide bonds, which efficiently facilitate the siRNA
release and in vivo activity.89 In another study, Lai et al.
synthesized an acid-labile cationic copolymer, consisting
of a hydrophilic poly(ethylene glycol) (PEG) block and a
polymethacrylamide block bearing tertiary amines linked
by acid-labile ortho ester rings in side chains (PAOE),
via RAFT polymerization for in vitro DNA delivery. Their
copolymers efficiently condensed plasmid DNA at neutral
pH by forming nanoscale polyplexes while the efficient
dissociation of polyplexes accompanied by an enhanced
DNA release was observed through the hydrolysis of ortho
ester group in the side-chains of PAOE at mildly acidic
pH. The in vitro results suggest that with further mod-
ifications, this pH-triggered DNA release strategy can be
a promising approach for the efficient intracellular delivery
of not only DNA but also other nucleic acid therapeutics.90
Recently, Yu et al. proposed a new type of linear
copolymer, poly(ortho ester amino alcohols) (POEAAs),
obtained by ring-opening polymerization (Fig. 4). Their
POEAAs possess uniform distribution of tertiary amine
main-chains among the abundant hydroxyl groups and
acid-cleavable tertiary amine side-chains. The cytotoxicity,
hydrophilicity, and DNA condensation ability of these
polymers were controlled through the amount of diglycidyl
ether moieties. The hydrolysis of ortho ester bonds at
mildly acidic pHs through the cleavage of tertiary amines
in the polymer side chains enhance the in vitro transfection
efficiency and DNA release.91
The pH responsive miRNA delivery has recently been
investigated in the work of Jung et al. They designed
doxorubicin (DOX)-tethered linear polyethylenimine
(LPEI) conjugates linked via a pH-responsive hydrazone
bond (LPEI-HZ-DOX), which was further complexed
with miRNA-34a for the co-delivery. The designed
biocompatible system provides successful simultaneous
release at acidic pH resulting in synergistically enhanced
in vitro toxicity and antiproliferation activity against
PC-3 cancer cells.92
Most of the pH-responsive polymers and their coun-
terparts modified by dynamically covalent linkages
mentioned above have been used mainly based on
the endo/lysosomal pH-triggered endosomal escape,
shielding/masking or micelle triggered release. However,
there are very few studies addressing the tumor targeting
issues using pH-responsive materials since it is difficult to
respond small pH changes as in tumor tissues. Considering
this, Bae et al. developed a polymer system which can
FIG. 3. pH-responsive photopolymerized diacetylenic amphiphile
(PDA) micelles for the intracellular siRNA delivery. Reproduced with
permission from American Chemical Society.76
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respond to small pH changes and used this polymer to
target acidic extracellular matrix of tumors. They
electrostatically coated the polyplexes with ultra pH-
sensitive poly(methacryloyl sulfadimethoxine)-b-PEG
diblock copolymer. The cytotoxic and transfection effect
of their gene delivery system drastically changes upon the
change in pH 7.4 (normal tissue) to 6.6 (tumor).
Furthermore, they developed a biodegradable pH-
sensitive diblock copolymer (poly(L-cystine bisamide-
gsulfadiazine)-b-PEG) as an alternative coating material
for positively charged polyplexes or other nanopar-
ticles.93 In another study, Tangsangasaksri et al. de-
veloped polyion complex (PIC) micelles coupled with
a smart polymeric shell and a pH responsive peptide that
are capable of targeting tumor and escaping endosome for
enhanced siRNA delivery. They used disulfide cross-
linking and copper-free click reaction in their design.
This delivery system enabled a charge change from
negative to modestly positive in slightly acidic tumor
environment (pH ;6.7) and further highly positive
charge state in late endosomal compartments where the
pH is lower (pH ;5.0). This stepwise charge change
strategy provides selective binding to cancer cell surfaces
and subsequent endosome disruption. Their results show
improved silencing activity which are correlated with
the facilitated cellular uptake at the acidic pH and the
efficient endosomal escape.94 Very recently Fan et al.
proposed a novel pH-responsive strategy based on the
conjugation of poly(ethylene glycol) modified by catechol
group (PEG-Cat) and phenylboronic acid terminated poly-
ethylenimine (PEI-PBA) via the borate ester formed be-
tween PBA and Cat. The pH-dependent stability of borate
ester in aqueous medium makes it possible to shield the
PBA ligand during the systemic circulation to provide
tumor targeting. The PEG domain was detached to expose
the tumor to PBA at acidic tumor environment (pH ;6.5)
while the PBA ligand enhanced the cellular internalization
through binding with overexpressed sialic acid residues on
cancer cells. In this design, siRNAs were used as both
a payload coupled with PBA moieties through their 39-ends,
and pH-responsive intermolecular cross-linker, providing
stability during blood circulating and pH triggered release at
acidic endosome/lysosome. Their results indicate promising
in vitro and in vivo performance.95
This section briefly summarizes that the pH-responsive
polymers and related chemistries can be used in many
different ways to solve different obstacles of gene de-
livery. However, the sole use of pH-responsive poly-
mers is not sufficient to address all of the hurdles of
gene delivery.
B. Temperature responsive designs
Temperature responsive polymeric materials have been
extensively used in the construction of new systems
FIG. 4. Illustration of POEAAs mediated controlled DNA release and serum tolerance. Reproduced with permission from Elsevier.91
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intended for gene delivery applications. These polymeric
materials containing thermo-responsive units can revers-
ibly exhibit phase transition at certain temperatures,
which results in changes in conformation, solubility
and hydrophilic–hydrophobic balance. For the polymers
becoming soluble upon heating, the transition temper-
ature is defined as upper critical solution temperature
(UCST), while for the polymers, which turn insoluble
upon heating, the transition temperature is defined as
lower critical solution temperature (LCST). The polymers
with LCST possess extended conformation below the
phase transition temperature, whereas above LCST, they
collapse and cannot interact with the surroundings.96
In gene/drug delivery applications, the collapse of
polymer structure upon endogeneous temperature increase
can be used as a strategy to control tumor targeting,
cellular uptake and release of the cargo. Since the
endogenously local temperature of a solid tumor is
slightly higher than that of the normal body temperature,
the LCST of a thermosensitive block copolymer can be
set to a desired point by manipulating the block ratio to
provide accumulation of the designed delivery system into
the tumor site. In addition, these thermoresponsive block
copolymers form micelles upon temperature changes
favoring cellular uptake and efficient cargo release.
The thermoresponsive copolymers have been synthesized
by different methods such as ATRP,97 radical addition
fragmentation transfer (RAFT) polymerization98 and con-
densation of both polymer parts together by activating the
terminal end group and coupling it with an amine from the
second polymer.99 The literature survey revealed that the
ATRP is the most-used method for the development of
thermo-responsive copolymers due to its precise control
over the polydispersity and molecular weight.
Among the wide range of synthesized thermally
responsive block copolymers, N-isopropylacrylamide
(NIPAAM) is the most used block in the development
of drug/gene delivery systems due to its LCST (ranges
between 30 and 50 °C). Its properties can be controlled
through co-monomer composition, hydrophilic/hydrophobic
balance and stereochemistry. The co-polymerization of
NIPAAM with other hydrophilic or hydrophobic mono-
mers results in the tuning of LCST of PNIPAAM.100,101
The water soluble PNIPAAM possessing flexible coil
conformation at low temperatures collapses into a
globule conformation upon the temperature increase
above LCST.100,102,103 These polymers become
amphiphilic in aqueous solution above body temper-
ature and self-assemble to encapsulate or integrate
hydrophobic and/or hydrophilic molecules. Many
thermoreversible copolymers based on PNIPAAM
have been reported in literature for the development of
novel nonviral vectors for gene therapy, including N-N,N-
trimethyl chitosan chloride-g-(N-isopropylacrylamide),103
poly(llysine)-g-poly(N-isopropylacrylamide),104
PNIPAAM-b-polyethyleneimine.105,106 It was pointed
out that the majority of temperature sensitive nonviral
vectors are limited to PNIPAAm-based copolymers.107,108
However, PNIPAAm based temperature responsive
copolymers synthesized by conventional free radical
polymerization do not possess narrow polydispersities
and well-defined architecture. Furthermore a recent
study demonstrated that PNIPAAm shows a potential
safety issue with an increased toxicity at physiological
temperature.108,109 Constructing a safe and nontoxic
thermoresponsive polymer-based vector with well-
fined molecular architecture, controlled molecular
weight and polydispersity motivated researchers for
new alternatives. Calejo et al. synthesized copolymers
of NIPAAM and (3-acrylamidopropyl)trimethylam-
monium chloride (AMPTMA) [PNIPAAMn-b-PAMPT-
MAm (1)], which were distinct in terms of the length of
the temperature-responsive PNIPAAM and the posi-
tively charged PAMPTMA block. Contrary to the other
studies, they used lower molecular weight polymers with
shorter charged blocks to reduce the cytotoxic potential
of the system. The synergetic effect of cationic and
hydrophilic segment and thermo responsive segment
contracting upon endogenous temperature provide an
advantage over the existing systems in higher DNA
loadings.107 With a similar strategy Ma et al. synthesized
a novel temperature responsive polymer poly PDMNIB
possessing main and side chains with different func-
tions. The main chain contains 2-(dimethylamino)ethyl
methacrylate which can interact with DNA, while, the
side chain, grafting onto the main chain by cis-
butenedioic anhydride, contains N-isopropylacrylamide
which is sensitive to temperature. This structure provides
a separation in two different functional chains of
PDMNIB. The unique structure of PDMNIB bearing
grafted moieties on the polymer backbone provides
a good advantage over its counterparts in terms of
efficiency. However, the LCST of this polymer
(;20 °C) makes its application restricted in some
parts of the body.110 Yang et al. synthesized thermo-
responsive poly[2-(2-methoxyethoxy)ethyl methacrylate]-
b-poly(2-hydroxyl methacrylate) block copolymers
(PMEO2MA-b-PHEMA) which were then grafted with
LMW PEI1200, to form PEI-g-(PMEO2MA-b-PHEMA)
copolymer vectors. The increase in grafting number of
PEI on block copolymer increases the LCST due to the
increase in hydrophilicity of macromolecular chains.
While temperature was elevated above LCST, PEIMH
was shown to condense DNA more efficiently due to
the shielding effect of collapsed PMEO2MA chains.
Moreover, the simultaneous contraction of PMEO2MA
chains led to more surface positive charges of PEIMH-1/
pDNA complexes, which is favorable for gene transport.
Although it may not be feasible for most cases, a short-
time cooling shock could increase the transfection
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efficiency. In addition, temperature response dependent
transfection efficiency of this system was changed accord-
ing to cell type indicating cell specificity.111 The overview
of these mentioned studies points out that the structure,
point of attachment and conformation of responsive seg-
ments play a critical role in the temperature responsive
dependent transfection efficiency. This determines how
well the responsive segment demonstrates its efficiency as
shown in recent studies. It was noted that the use of grafted
block copolymers provide better results than that of their
counterparts. Unlike the above mentioned studies, in
our previous works, we proposed the use of temperature
responsive Pluronic F127 triblock copolymer in the
construction of cationic and amphiphilic pentablock
copolymers for in vitro and in vivo DNA and siRNA
delivery applications. In our approach, the middle Pluronic
F127 block acted as stabilizer, shielding agent and en-
hanced cellular uptake through temperature responsive
micellization, showing very promising results.41,68,112–114
Different thermo-responsive polymer combinations
have also been used recently. Tachaboonyakiat et al.
used poly(vinylamine-co-N-vinylisobutylamide) or
poly(VAm-co-NVIBA) to stabilize double-stranded DNA
(dsDNA) through the controlled formation or dissociation
of PICs. In their design, the cationic poly(vinylamine)
(VAm) block enables electrostatic complexation
with anionic DNA while the thermally responsive
poly(N-isobutylamide) (NVIBA) block enables protec-
tion of DNA helical structure and limits the strength of
the electrostatic interaction. Their results show that the
use of thermoresponsive polymer blocks is a promising
strategy to control the formation/dissociation of the
copolymer/dsDNA complexes and maintain the DNA
helical structure.115 In another work, Cardoso et al.
evaluated the ability of thermoresponsive block
copolymers comprised of N-isopropylacrylamide and
(3-acrylamidopropyl)trimethylammonium chloride
blocks for enhanced in vitro siRNA delivery
(Fig. 5). They indicated that the cloud point and
therefore the transition temperature of the polymer, where
the aggregation or precipitation of the polymer molecules
becomes thermodynamically more favorable, determines
the toxicity and silencing efficiency of their design.116
The thermo-responsive nonviral vectors have also been
developed for the disruption of the endosomal/lysosomal
compartment. Park et al. reported a different temperature-
sensitive gene delivery system based on hydrogel nano-
particles, which were achieved by crosslinking activated
Pluronic with PEI, through a modified emulsification/
solvent evaporation method. These nanoparticles show
a thermally reversible swelling, which in turn induces
the endosomal disruption, upon the temperature decrease
from 37 to 20 °C.117 They noted that when the nano-
particles were used for in vitro siRNA delivery, the applied
cold-shock treatment enhanced the siRNA activity.118
This observation is in accordance with the findings in
literature indicating that cold-shock treatment enhances
plasmid expression or RNAi activity. However, the
cold-shock treatment is not easy to apply to practical
in vivo uses.
Another use of thermo-responsive polymers can
also be used for cancer-targeted gene delivery in
response to hyperthermic conditions in the tumor.
For example, poly(N,N-diethylacrylamide-co-acrylamide)-
block-poly(c-benzyl L-glutamate) based self-assembled
thermo-responsive nanoparticles were designed for
targeted drug delivery in localized hyperthermia.
Considering the local hyperthermia (about 43 °C) as
stimuli, the lower critical solution temperature (LCST)
of nanoparticles was adjusted to a desired level.119
In another work, PEI and NIPAM-derived cationic
thermo-responsive copolymers with a tunable LCST
FIG. 5. Thermoresponsive block copolymers comprised of poly(N-isopropylacrylamide) and of poly[(3-acrylamidopropyl)trimethylammonium
chloride] blocks for enhanced in vitro siRNA delivery. Reproduced with permission from American Chemical Society.116
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between 37 and 42 °C effectively condensed DNA and
formed small, charge neutral polyplexes.120 Significant
accumulation of the thermo-responsive polyplexes in the
hyperthermically treated neuroblastoma tumor in mice
and subsequent enhanced DNA transfection in vivo was
reported.121
The thermo-responsive hydrogels and nanogels were
also preferred to provide on-off type controlled release
profile due to their ability of shrinking/expanding and the
close packing of the fully collapsed gel upon heating. For
example, the polymer network composed of PNIPAAM
and poly(teramethylene ether glycol) (PTMEG) shows no
release of active agent at temperatures around 30 °C,
whereas they enable an increased release at lower
temperatures.122 The properties of those thermo-responsive
hydrogels can further be enhanced to provide additional
responsive properties such as pH-responsiveness. For
example, PNIPAAM was cross-linked with dendritic
polyglycerol modified with acrylate groups to form a
nanogel using a precipitation polymerization method.
The presence of the polyglycerol enhanced the water
solubility, the biocompatibility, and allowed fine-tuning
of the thermo-responsive behavior of the nanogel.123
The mentioned studies indicated that the thermorespon-
sive polymers need further optimization in terms of safety
aspects and applicable temperature range. The findings
proved that when the temperature responsiveness is
used with other stimuli responses, such as pH or redox
potential, the higher gene delivery efficiencies are
possibly achieved.
C. Redox potential responsive designs
The difference of redox potential existing between
the oxidative extracellular space and the reductive intracel-
lular space has been used as an efficient strategy for the
development of responsive gene delivery vectors. The redox
potential mainly stems from the intracellular and extracellu-
lar glutathione concentration difference, which is used as
a triggering mechanism.124 As mentioned earlier, the con-
ventionally used cationic homopolymers suffer from the
toxic effects due to their excess cationic charge and in-
hibition of cargo release caused by their strong electrostatic
interactions. On the other hand, the use of redox responsive
chemical conjugation alone or in combination with electro-
static interactions enhance nucleic acid release and decrease
toxicity.71 Breunig et al. hypothesized that disulfide
cleavable carrier systems are favorable for the release
of siRNA into the cell cytoplasm. They tested various
PEI derivatives (linear PEI, disulfide cross-linked PEI,
and branched PEI) electrostatically complexed with
siRNA. The results indicate that the in vitro cellular
uptake of siRNA is enhanced by branched PEI; however,
an efficient siRNA release was achieved by cleavable
disulfide cross-linked PEI. Hence, they suggested
a combination of a high branching density and reduc-
tively cleavable bonds within the PEI-based carrier
system as a potential siRNA delivery system. The only
concern regarding this study is the potential toxic
effect of PEI at certain doses and off target effects.25
The facilitated release accompanied by proper targeting
features can be provided by multiconjugate strategy. York
et al. developed N-(2-hydroxypropyl) methacrylamide-
s-N-(3-aminopropyl) methacrylamide (HPMA-s-APMA)
copolymer by using multifunctional cross linker,
N-succinimidyl 3-(2-pyridyldithio)-propionate (SPDP),
attaching a fraction of the primary amine, APMA, to
thiolated siRNA through a disulfide exchange reaction
while the unmodified APMA portion was coupled to
amine reactive folates for targeting. These modifications
resulted in the formation of a multifunctional copolymer
both capable of in vitro cellular targeting and providing
easy siRNA release.125
The advantages of micellization in delivery systems
such as enhanced blood circulation, stability and cellular
entry have already been mentioned. The use of polymeric
micelles in combination with chemical conjugation
strategy was also proposed to further enhance the effi-
ciency of the systems. Matsumoto et al. reported a poly
ion complex (PIC) micelle in vitro siRNA delivery system
based on poly(ethylene glycol)-blockpoly(L-lysine)
(PEG-b-PLL) block copolymer modified with
2-iminothiolane (2-IT) cross-linking reagent. The revers-
ible nature and susceptibility to reduction at the subcellular
level makes the covalent disulfide cross-links particularly
attractive for micelle core stabilization. The free sulfhydryl
groups provide enhanced stability through disulfide cross-
linking in the micelle core while the cationic amidine
groups allowed PIC formation with anionic siRNAs.
However, micelle formation occurs only at specific molar
ratios of polymer/siRNA, which can be controlled by
IM content in the PLL block. This situation could
possibly stem from the instability of amidines formed
with 2-iminothiolane.126 The formation and properties
of the micelles were also changed depending on the type
of cross linker used and degree of cross linking, which in
turn determines the polymer charge density and optimal
conditions for micelle formation. The higher crosslinking
degrees decrease the polymer charge density leading to
the use of higher polymer amount for complexation with
nucleic acids. On the other hand, the higher micelle
stability, which also brings loss of sensitivity to disulfide
reducing conditions, leads to lower siRNA activity.
Therefore, the degree of reversible micelle stability is
critical to achieve high gene silencing at the target site.127
The redox potential response is also used for miRNA
delivery. Li et al. used bio-cleavable disulfide
linkage to develop an amphiphilic cationic graft
polymer [polyethylenimine-cystamine-poly(e-caprolactone)
(PSSP)] based on coupling of poly(e-caprolactone) (PCL)
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with polyethylenimine (PEI) blocks for miR-34a delivery.
They reported that the degradable micelles provided low
cytotoxicity, intracellular redox potential triggered miRNA
release and high in vitro transfection efficiency.128
The mentioned studies above did not address
endosomal escape property since the redox potential
itself is not sufficient to solve the problems related to
the endosomal escape. However, it can be used along
with the pH-responsive endosomal escaping polymers
to facilitate the nucleic acid release. Lundy et al.
described neutral, ampholytic conjugatable diblock
polymer micelles composed of a hydrophilic poly(N-
(2-hydroxypropyl)methacrylamide-co-N-(2-(pyridin-2-
yldisulfanyl)ethyl)methacrylamide) (poly[HPMA-co-
PDSMA]) block to promote aqueous stability and facilitate
thiol-disulfide exchange reactions and an ampholytic
block consisting of propylacrylic acid (PAA), dime-
thylaminoethyl methacrylate (DMAEMA), and butyl
methacrylate (BMA). These block copolymers are capable
of forming self-assembled polymeric micelles under
aqueous conditions. Neutral hydrophilic micelles with
membrane destabilizing activity at acidic pH-induced
the endosomal escape, while the attachment of thiolated
siRNA via the disulfide exchange reaction with the
pyridal disulfide groups facilitate the release.129 There
are also some cases in which the redox potential was
used for conjugating peptides to polymers to enhance
properties. Segura et al. reported the synthesis of ABC
triblock copolymer composed of poly(ethylene glycol)
(PEG), poly(propylene sulfide) (PPS), and a positively
charged peptide (PEG-PPS-peptide) for siRNA delivery
applications. They synthesized the diblock copolymer
PEG45-PPS5,10 through the anionic polymerization
of propylene sulfide upon a PEG macroinitiator. The
hydrophobic portion of this polymer facilitates the self-
assembly having hydrophilic core. Following this, the
TAT or oligolysine peptide was coupled to the PPS
terminus via disulfide exchange reaction using N-terminal
cysteine residue on the peptide. The peptide was designed
to interact electrostatically with siRNA to both condense
siRNA and enhance cellular entry.52 In another study,
Zhang et al. reported polyarginine disulfide-linked PEI for
in vivo miR-145 delivery to prostate cancer (Fig. 6). The
systemic administration of the R11-SSPEI/FAM-miR-145
complex to the peritoneal mouse tumor model resulted in
miR-145 delivery into the tumors, tumor growth inhibition
and prolonged survival time in vivo.130
Supramolecular complexes can also be achieved using
redox potential responsiveness. Hu et al. developed a
polymer-based nanosystem for functional gene therapy by
synthesizing a supramolecular complex self-assembled
from polycations and functional adamantyl modules for
miR-34a delivery. Their design provided proton sponge
effect by polycations for endosomal escape, PEGylation
protection for stability, and controlled release by breakdown
of disulfide bonds through redox-responsiveness, therefore
enabling enhanced in vitro and in vivo activity.131
As a short conclusion, the use of redox potential to
provide a better release of nucleic acids at desired target
site is an efficient strategy to enhance the nucleic acid
activity. With this tool, the difficulties in electrostatic
complexes such as poor release and possible toxicity
FIG. 6. Schematic illustration of R11-SSPEI/miR-145 polyplex synthesis. Reproduced with permission from Elsevier.130
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caused by excess cationic charge can be overcome.
However, the redox potential itself is not sufficient to
deal with the other hurdles of nucleic acid delivery such
as cellular entry and endosomal escape; therefore, it should
be used in combination with other stimuli responses.
D. Dual and multi responsive designs
The presence of multiple barriers in gene delivery
has brought the use of polymeric vectors possessing
simultaneous dual or multiple response properties.
Various combinations of internal stimulus (such as
pH-temperature, pH-redox potential, temperature-redox
potential or pH-temperature-redox potential etc.) can be
achieved by bringing polymers with different stimuli
responsiveness together (Table I). In these designs, each
polymer segment is used to overcome a different barrier.
Different dual or multiple responsiveness combinations
have been used to address the problems of gene delivery.
In our group, we have synthesized pH and temperature
responsive pentablock copolymers, composed of temper-
ature responsive Pluronic F127 [poly(ethyleneoxide)-
block-poly(propyleneoxide)-block-poly(ethyleneoxide)
(PEO-b-PPO-b-PEO)] and pH-responsive cationic
PDEAEM [poly(2-diethylaminoethyl methacrylate)]
blocks, via ATRP. These polymers were specifically
used for both pDNA and siRNA delivery, as well as
a vaccine carrier, due to their several advantages in
eliminating the intra/extra cellular barriers over their
counterparts. The central triblock Pluronic F127 in the
pentablock copolymer contributes to the temperature re-
sponsive micellization and has been reported to be able to
promote cellular entry while the pH-responsive cationic
end blocks, PDEAEM, facilitate nucleic acid condensation
and endosomal escape.41,68–70,113,114,132–139 Thermorever-
sible micellization occurs in aqueous solutions because of
the lower critical solution temperature (LCST: ;8 °C) of
the hydrophobic poly(propyleneoxide) (PPO) block in
the middle of Pluronic F127. The presence of
TABLE I. Polymer based stimuli responsive gene (DNA and small RNAs) delivery vectors.
Vector Production method Stimuli response
Nucleic
acid
Target barrier and
improved property Reference
Star shaped PDMAEMAs ATRP pH DNA Endosomal escape & enhanced
transfection
73
Poly(EAA-co-BMA)-b-NASI-g-(HMA-
co-TMAEMA)
Grafting & electrostatic
interactions
pH siRNA Endosomal escape & enhanced
release
68
BMA, PAA, and DMAEMA RAFT pH siRNA Endosomal escape & enhanced
release
67
Star-branched PLA-PDMAEMA Combination of ring-opening,
ATRP, and click chemistry
via an “arm-first” approach
pH miR-2li Enhanced transfection & tumor
inhibition
74
PNIPAAMn-b-PAMPTMAm . . . Temperature DNA DNA loadings 93
PEI-g-(PMEO2MA-b-PHEMA) . . . Temperature DNA DNA loadings 97
Copolymer of N-isopropylacrylamide
and (3-acrylamidopropyl)
trimethylammonium chloride
ATRP Temperature siRNA Reduced toxicity & enhanced
silencing efficiency
116
HPMA-s-APMA RAFT Redox potential siRNA Enhanced release 111
PEG-b-PLL . . . Redox potential siRNA Enhanced release 112
Graft polymer (polyethylenimine-
cystamine-poly(e-caprolactone)
(PSSP)) based on coupling of poly
(e-caprolactone) (PCL) with
polyethylenimine (PEI)
. . . Redox potential miR34a Reduced toxicity & enhanced
release & transfection efficiency
128
PDEAEM-PluronicF127-PDEAEM ATRP pH & temperature DNA Stability & cellular uptake &
endosomal escape
41,98–
101,115–
124
PNIAPM-CS/PDMAEMA ATRP & click chemistry pH & temperature DNA Stability & cellular uptake &
endosomal escape
126
PEEP-b-PDMAEMA ATRP-ROP pH & temperature . . . . . . 127
PEG-PAsp(DET-Aco) Cross linking & electrostatic
interactions
pH & redox
potential
DNA Endosomal escape & enhanced
release
128
4-Arm poly(ethylene glycol)-b-poly
(disulfide histamine) copolymer
Michael addition reaction pH & redox
potential
DNA Endosomal escape & enhanced
release
129
(PEO-b-PAA-b-PNIPAAM) One-pot RAFT Temperature &
redox potential
DNA Enhanced release 130
AuNP-PDEAEM-PluronicF127-
PDEAEM
ATRP & electrostatic
interactions
pH & temperature
& redox
potential
siRNA Stability & cellular uptake &
endosomal escape & enhanced
release
110
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hydrophobic PPO chains provide copolymers with the
unique ability to be incorporated into cell membranes by
enhancing cell interactions and increase translocation of
delivery systems into the cells, with minimal damage to
the cell membrane integrity.112,133,140 The end blocks, poly
(diethylaminoethyl methacrylate) (PDEAEM), are the
essential functional cationic segments (pKa ;7.3) to
complex with pDNA or siRNA and to provide pH
buffering capacity at low pH of the endosome with their
protonatable tertiary amine groups that aid in the release of
entrapped delivery systems from the acidic endosomal
vesicles through the proton sponge mechanism
(Fig. 7).41,68,112
Unlike with the use of cationic polymers such as
PEI, the cytotoxicity of these pentablock copolymers
can be tuned by changing the balance between the
cationic and nonionic blocks.70 In addition to their use in
polyplex form, these distinguished polymers have recently
been proven to be eligible candidates for the development
of multilayered siRNA delivery nanostructures.71
ATRP reactions can also be used in combination with
other methods. For example, Bao et al. proposed a comb-
like dual hydrophilic graft chitosan terpolymer by means
of ATRP and click chemistry. Following the synthesis of
PDMAEMA and PNIPAM via ATRP and subsequent
substitution of the halide end groups with azido groups,
the azide modified polymers were grafted to the alkynyl
modified chitosan backbone via click chemistry. They
demonstrated that the core–shell structured micelles with
PNIAPM as a core and CS/PDMAEMA as a shell were
formed in acidic environment (pH , 4) at elevated tem-
perature (. 38 °C), whereas the unimers turned into the
micelles with CS/PDMAEMA cores in alkaline solutions
(pH . 7) at room temperature.141 As another approach,
Liu et al. synthesized pH- and temperature-responsive
double-hydrophilic poly(ethylethylene phosphate)-block-
poly[2-(dimethylamino)ethyl methacrylate] (PEEP-b-
PDMAEMA) diblock copolymers via the combination of
ring-opening polymerization (ROP) and ATRP intended
for gene delivery applications.142
Redox and pH-sensitive dual responsive polymers
have also been used for gene delivery applications.
Sanjoh et al. described a multifunctional pDNA delivery
vector which is able to enhance the endosomal escape
and cytosolic release of cargo through the pH-responsive
membrane-destabilizing activity in acidic late endosomal/
lysosomal compartments and reduction of disulfide cross-
links in the intracellular environment, respectively. The
ternary polyplexes formed based on a template binary
polyplex of thiol group bearing poly(L-lysine) and pDNA,
obtained through disulfide crosslinking, and subsequent
coating of this binary polyplex with poly(ethylene glycol)-
b-poly(aspartamide(DETAco)) (PEG-PAsp(DET-Aco))
through electrostatic interactions. PEG-PAsp(DET-Aco)
assists in the endosomal escape of pDNA following
endocytosis through its degradation at acidic pH while
the existing cleavable disulfide bonds provide reversible
stability and facile pDNA release. The system showed
good transfection efficiency without significant toxicity.
However, it lacks cell targeting features.143 An et al.
synthesized 4-arm poly(ethylene glycol)-b-poly(disulfide
histamine) copolymer by Michael addition reaction to
address the pH-targeting gene delivery. Their copolymer
was able to rapidly dissociate to promote DNA release in
the presence of 10 mM glutathione (intracellular reducing
environment) and reveal pH-responsive surface charges
at low pH values (pH 6.3 tumor microenvironment). It is
hypothesized that the polyplexes of the copolymer have a
neutral surface under physiological conditions. However,
the positive surface in an acidic tumor microenvironment
obtained by the protonation of imidazole groups in
histamine residues induced the cellular uptake of the
polyplexes in tumor cells. Their results represent
enhanced transfection efficacy in cancer cells under acidic
conditions (pH 6.3–7.0).144
Qian et al. proposed folate-decorated hydrophilic cationic
star-block terpolymer, [poly(L-glutamic acid c-hydrazide)-
b-poly(N,N-dimethylaminopropyl methacrylamide)]
3-g-poly(ethylene glycol) ((PGAH-b-PDMAPMA)3-
g-PEG), with disulfide linkages between the PEG and
PDMAPMA blocks, for targeted co-delivery of doxorubicin
and Bcl-2 small interfering RNA (siRNA) into breast cancer
cells. They used a combination of ring-opening polymeriza-
tion, reversible addition-fragmentation chain transfer poly-
merization, PEGylation and hydrazinolysis for the polymer
synthesis. They conjugated the terpolymer to doxorubicin via
an acid-labile hydrazone linkage while simultaneously form-
ing electrostatic complexes with siRNA. They found that
doxorubicin and siRNA showed pH and reduction dual
dependent release characteristics. Their overall results in-
dicate that this vehicle design can provide targeted intracel-
lular co-delivery of doxorubicin and therapeutic siRNA and
be a promising strategy in cancer therapy.145
Unlike the other studies, Xu et al. used temperature-
responsive triblock copolymer, which was (PEO-b-
PAA-b-PNIPAAM) synthesized by a one-pot RAFT
polymerization and further cross-linked using cyst-
amine after vesicle formation, to provide temperature
FIG. 7. Structure of pentablock copolymers. The number of repeating
units of the PDEAEM blocks, n, was varied to control the properties of
the copolymer. Reproduced with permission from Elsevier.68
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and cleavable disulfide bond dependent cargo release.146
On the other hand, Wen et al. designed a dual functional
gene carrier system of redox-sensitive star-shaped cationic
polymer with multiple arms consisting of pDMAEMA
linked to a b-cyclodextrin (b-CD) core with bioreducible
disulfide bonds (bCD-SS-pDMAEMA) and adamantyl end
capped pMPC (Ad-pMPC). Their system was responsive
to degradation by disulfide bond reduction and zwitter-
ionic phosphorylcholine based extracellular stabilization
and induced cellular uptake.147
Although the dual responsive systems may address most
of the problems with the gene delivery, there are still some
deficient aspects. For instance, a pH and temperature
responsive system can facilitate endosomal escape through
pH responsiveness and enhance cellular uptake and sta-
bility through temperature responsiveness. However, such
a system complexed with DNA or siRNA through elec-
trostatic interactions may face some difficulties in efficient
cargo release. On the other hand, a system using redox
potential to facilitate gene release and pH response to
provide endosomal escape may suffer from stability or
cellular uptake. Considering these pros and cons, multi-
responsive polymer based gene delivery systems have
been proposed to address all the current issues.
For instance, Klaikherd et al. reported a triple stimuli-
sensitive block copolymer assembly which shows re-
sponse to temperature, pH and redox potential (Fig. 8).
Their block copolymer design constitutes an acid-sensitive
THP-protected HEMA as the hydrophobic core and a
temperature-sensitive PNIPAM as the hydrophilic shell
with a redox-sensitive disulfide bond at the interface. The
hydrophobic core involves acid-sensitive cleavable cyclic
acetal functionality. The transformation of hydrophobic
core to hydrophilic PHEMA following the acetal group
cleavage results in an imbalance in the hydrophilic/
lipophilic ratio disruption of the micelle leading to the
release of cargo. The cleavage of disulfide bond, connect-
ing the hydrophobic and hydrophilic blocks, in presence of
glutathione causes micelle disruption and the release of the
cargo. Their results show that multi stimuli responsiveness
gives the opportunity of fine tuning of the release kinetic
properties and targeted delivery.148
Dong et al. reported a novel multiple stimuli-
responsive polymeric micelle composed of a photo-
responsive shell and a temperature/pH responsive
core. They prepared light-sensitive pyrene chromo-
phore incorporated temperature/pH sensitive polymer,
poly(dimethylaminoethyl methacrylate) (PDMAEMA),
via ATRP. PDMAEMA exhibits hydrophilicity below
the LCST, while hydrophobicity above the LCST.
PDMAEMA chains are hydrophilic at low pH due to
protonated tertiary amine groups, whereas PDMAEMA
chains are hydrophobic at high pH due to the uncharged
tertiary amine groups. The micelles dissociate under UV
irradiation and shrink when the temperature is increased
above the LCST and swell/dissociate (pH 3) or collapse
(pH 10) depending on the pH. They proposed that this
system works well for the controlled release
applications.149
In recent work, Ma et al. used traditional host-guest
interactions to develop a delivery system based on the
poly(methyl vinyl ether-alt-maleic acid) [P(MVE-alt-MA)],
host polymer bcyclodextrin-grafted P(MVE-alt-MA)
[P(MVE-alt-MA)-g-b-CD], and guest polymer azobenzene-
grafted P(MVE-alt-MA) [P(MVE-alt-MA)-g-azo].
They obtained multiple stimuli-responsive physical
P(MVE-alt-MA)-g-b-CD/P(MVE-alt-MA)-g-azo supramo-
lecular hydrogels through the simple mixing of host
and guest polymers. These supramolecular hydrogels
exhibited photo-, pH-, and thermo-sensitivity. Ovarian
cancer SKOV3 cells can survive within different hydrogel
layers, which were observed by confocal microscopy.
They suggested these multiple stimuli-responsive
P(MVE-alt-MA)-based supramolecular hydrogels as a
three-dimensional (3D) cell culture matrix or as a vehicle
for the delivery of drugs and therapeutic cells.150
Polymers can be used in combination with other
nanoparticles (such as gold, silica, iron oxide, quantum
dots etc.) to create multicomponent/layer gene delivery
systems to provide multiple responsiveness. In particular,
gold nanoparticles (AuNP) have been used in combina-
tion with polymers due to their available surface chem-
istry for the introduction of cleavable redox responsive
disulfide bonds which facilitate nucleic acid release and
FIG. 8. Multi-stimuli sensitive amphiphilic block copolymer assemblies. Reproduced with permission from American Chemical
Society.148
M. Uz et al.: Stimuli responsive polymer-based strategies for polynucleotide delivery
J. Mater. Res., Vol. 32, No. 15, Aug 14, 20172944
https://www.cambridge.org/core/terms. https://doi.org/10.1557/jmr.2017.116
Downloaded from https://www.cambridge.org/core. Izmir Yuksek Teknoloji Enstitusu, on 31 Oct 2017 at 05:51:58, subject to the Cambridge Core terms of use, available at
enhance activity.83,151–157 Considering this fact, in our
recent study, we have used temperature and pH respon-
sive cationic and amphiphilic pentablock copolymers,
which consist of the temperature responsive triblock
Pluronic F127 sandwiched between the pH responsive
PDEAEM [poly(2-diethylaminoethyl methacrylate)] end
blocks, for the first time in the development of AuNP
based multicomponent siRNA delivery systems (MCSs).
We developed a multicomponent system (MCS) by the
subsequent deposition of siRNA and pentablock copoly-
mers on the AuNP surface through cleavable disulfide
bonds (to enhance siRNA release) and through the
electrostatic interactions (to protect siRNA, enhance
cellular uptake, endosomal escape, and siRNA activity),
respectively. In addition to the temperature and pH
responsiveness stemmed from pentablock copolymer,
the presence of cleavable disulfide bonds provide the
redox response making the whole system multi respon-
sive. Our results indicate that the MCS shows a very
good siRNA protection and stability, cellular uptake,
endosomal escape, and transfection efficiency without
severe toxicity.71
E. CRISPR/Cas9-sgRNA gene editing tool delivery
CRISPR/Cas9, a new gene editing technology, was
recently developed following the discovery of a new
immune system in prokaryotes.158 This system was de-
veloped by archaea and bacteria as a defense mechanism
against viruses and plasmids. In this mechanism, a segment
of invading DNA is copied into the host genome at a locus
of clustered regularly interspaced short palindromic repeats
(CRISPR), which serves as a genomic memory of invading
pathogens for future invasions.158–161 Therefore, during the
upcoming invasions, the specific locus transcribes corre-
sponding CRISPR RNA (crRNA) that is able to recognize
and base pare with the foreign DNA. The crRNA coupled
with an endogenous CRISPR-associated endonuclease
(Cas) causes double strand breaks in the pathogenic
DNA, inhibiting integration and replication of the path-
ogen.162,163 Following this discovery, the novel
CRISPR/Cas system has begun to be tested in eukary-
otic cells through the optimization of the Cas9 endonu-
clease to include nuclear localization signals for human
cells and synthesis of single guide RNA (sgRNA) to
target any 20-bp DNA sequence.163 An illustration of
the CRISPR/Cas9 system is shown in Fig. 9.
The CRISPR/Cas9 system is capable of binding to
any interested target DNA sequences via sgRNA to
achieve double strand breaks. However, the in vivo
delivery of CRISPR/Cas system is limited by its large
size (;4.2 kb), which makes it challenging to load to a
carrier vector.162,163 Although it is possible to load
CRISPR/Cas9 system to a cationic liposome or PEI based
vectors, the limitation in the endothelial gap size of blood
vessels prevents the delivery to target tissues for efficient
genome editing. A few cases of off-target mutagenesis
resulting from CRIPSR/Cas9 in human cells have been
reported, raising the concerns regarding the target-specific
delivery of CRIPSR/Cas9.162,163 However, this was
addressed by sgRNA optimization showing limited to no
off-target mutagenesis in vitro and in vivo.164 Therefore,
further research on CRISPR/Cas9 specificity, optimization
and delivery strategies will be needed for efficient thera-
peutic applications.
Various cationic liposome based nonviral delivery
vectors have been developed for an efficient CRISPR/
Cas9 system delivery, which was discussed elsewhere
in detail.162–164 As an alternative, cationic polymer based
nonviral vectors have also been investigated for
CRISPR/Cas9 system delivery. Mostly polyethyleneimine
(PEI) based vectors have been tested for CRISPR/Cas9
system delivery so far. The molecular weight, linearity and
degree of branching of PEI determines the properties of the
designed system such as toxicity, protective effect, endo-
somal escape through the proposed proton sponge effect.
For example, PEI-CRISPR/Cas9-mediated somatic genome
disruption was recently used to achieve the in vivo targeting
and deletion of tumor suppressor genes in the mouse brain.
In addition, various modifications of PEI were developed to
improve the transfection efficiency and decrease the cyto-
toxicity for efficient genome editing.163 Unfortunately, there
have not been many studies investigating the possible use of
stimuli responsive polymers for the CRISPR/Cas9 system
delivery yet, which can be addressed as a future direction.
FIG. 9. Schematic representation of the CRISPR/Cas9 complex.
(a) The CRISPR/Cas9 system with a single guide RNA (sgRNA)
and CRISPR-associated protein 9 (Cas9). (b) The target DNA
sequence. (c) sgRNA targets the complementary target DNA sequence,
and Cas9 nuclease follows to generate a double stranded break at the
target site. Reproduced with permission from Elsevier.158
M. Uz et al.: Stimuli responsive polymer-based strategies for polynucleotide delivery
J. Mater. Res., Vol. 32, No. 15, Aug 14, 2017 2945
https://www.cambridge.org/core/terms. https://doi.org/10.1557/jmr.2017.116
Downloaded from https://www.cambridge.org/core. Izmir Yuksek Teknoloji Enstitusu, on 31 Oct 2017 at 05:51:58, subject to the Cambridge Core terms of use, available at
F. Stimuli responsive polymer based gene
delivery systems for clinical trials
The clinical application of gene-based therapy for
treating cancer has been investigated over the past two
decades. However, the presence of various barriers
summarized in the previous sections has limited the
success of clinical trials, which could be enhanced by
the development of better functional carriers. Despite
the limitations, viral vectors have been used in approx-
imately 70% of the clinical gene therapy trials so far.165
Nevertheless, nonviral vector based gene therapy has the
potential to not only address the current limitations of the
viral vectors such as safety, immunogenicity, lower
payload, and easy synthesis, but also to allow novel
designs with multiple functionalities. These functionalities
are possible to achieve by the use of stimuli responsive
polymers.2,165 However, there are very few clinical trials
involving the use of stimuli responsive polymer based
vectors for gene therapy. One example includes PEGylated
PLL for DNA delivery minimizing the nonspecific inter-
action with serum components and increasing blood cir-
culation time. This system went to Phase I clinical trials
showing some evidence of gene transfer.166 In humans,
PEI has been studied for gene therapy of different cancer
types in various forms. A PEG–PEI–cholesterol lipopol-
ymer is under clinical investigation for immuno-therapy of
ovarian and colorectal cancers through forced expression
of the cytokine interleukin-12 (IL-12).
Among various other stimuli responses, the pH and
redox potential responsiveness are the most commonly
used, along with PEGylation for the clinical trials.2
However, a majority of these clinical trials are for drug
delivery. Vicent et al. designed a HPMA copolymer-based
conjugate, PHPMA-GPLG-AGM-Dox, where PHPMA is
poly[N-(2-hydroxypropyl) methacrylamide], using GPLG
tetrapeptide linker (Gly-Phe-Leu-Gly) that can be cleaved
by lysosomal thiol-dependency. This redox potential-
responsive system went clinical trials.167
A PEG-poly(aspartic acid) polymer-based micellar
formulation was designed for paclitaxel delivery. The
encapsulation of paclitaxel was facilitated through
increasing the core hydrophobicity by modifying half
of the carboxylate groups of poly(aspartic acid) with
4-phenyl-1-butanol PEGpoly (asp–phe). At physiological
pH, the free pendant carboxylate groups, located in the
cores of the micelles, are deprotonated providing the
stability for the micelles while at acidic pH, they get
protonated and accelerate the drug release. The promis-
ing results obtained from Phase 1 and 2 clinical trials
have led to Phase 3 trial in patients with metastatic
breast cancer.168–170
Various delivery system designs have been using
hydrazone linking and some of these designs have been
tested clinically. For instance, PEG polyaspartate block
copolymer attached with epirubicin via a hydrazone
bond was developed to enhance the antitumour activity.
The acidic conditions triggered the epirubicin release
due to the cleavage of acid labile hydrazone bond.
Preclinical studies indicate that 74% of the drug release
occurred at the tumor site. The studies resulted in pro-
ceeding to clinical trials with patients possessing various
cancer types.171,172
The use of small RNA delivery for gene-based therapy
has been proposed as a promising strategy based on the
current in vitro and in vivo investigations; however, small
RNA therapeutics and stimuli responsive polymer based
systems have not yet been fully tested in clinical trials.
Nevertheless, the recent progress in this field along with
the development of new vectors encourages the efforts.2
One of these efforts was the development of cyclodextrin
polymer (CDP)-based nanoparticles as an siRNA
delivery system that enters Phase I clinical trials for
cancer treatment.173,174
Progress in the use of stimuli responsive polymer-
based polynucleotide delivery systems in the clinical
trials cannot be underestimated; however, there is still
a long way for a successful treatment.
IV. CONCLUSIONS AND FUTURE OUTLOOK
Driving gene therapy to translation and clinical
applications is the main target of all gene delivery
research. Among the various strategies, polymer based
gene delivery systems play a crucial role in this regard.
Although the currently existing systems have been
addressed to overcome some of the extracellular and
intracellular barriers, an ideal system aimed at all the
conflicting demands of the gene delivery has not yet
been proposed. The delivery systems responding only
one stimulus and lacking multifunctionality may not be
efficient enough to achieve a significant in vivo thera-
peutic activity. Therefore, the development of virus-
mimicking, multi-functional stimuli-responsive polymer
based gene delivery systems have been proposed as an
efficient strategy for in vivo applications. Such an ideal
polymer based system developed for in vivo applications
should possess several functionalities that can be acti-
vated at certain stages of gene delivery. The selected
materials should be nontoxic, nonimmunogenic, and
biodegradable to prevent any side effects or undesired
interactions with the body compartments. The formed
system is expected to protect the loaded nucleic acids
from nuclease enzymes or serum proteins and provide
stability during the circulation in the body. This can be
achieved by hydrophilic shielding components, such as
PEG chains, providing stability and stealth properties
during circulation in the blood and reducing possible
toxicity while at the same time being able to be removed
at a certain site of action as a response to a stimuli to
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facilitate cellular uptake and endosomal escape. The
ligands on the system surface can be used to recognize
a specific cell/tissue, and facilitate cellular uptake through
receptor-mediated endocytosis. The temporary nucleic acid
loading through electrostatic interaction, covalent conju-
gation, or physical encapsulation is expected in the inner
part of the delivery system to provide protection against
premature release and enzymatic degradation. Besides the
nucleic acids, it is also applicable to incorporate other
drugs or imaging probes into delivery system structure to
enhance therapeutic efficacy and theranostic features. The
stable inner part should be able to disassemble at the
desired site of action (nucleus or cytoplasm) upon an
internal or external stimuli such as redox potential,
temperature change or pH change, to enable efficient
nucleic acid release. siRNA functions in the cytoplasm
while pDNA has to enter the nucleus for effective gene
expression. Therefore, the structure/functionalities of
the developed system can vary depending on the type
of nucleic acid, drug or imaging probe. In addition, it is
preferred that the inner part contains pH responsive
endosomolytic components or linkers that help the
endosomal escape. It is possible to achieve the men-
tioned properties using stimuli responsive (pH and
reduction potential, or temperature) polymers, how-
ever, it is still far off to gather all of these properties in
one unique and universal system.
As overviewed in this article, various stimuli-
responsive strategies have been used to develop nonviral
nucleic acid carriers that efficiently overcome multiple
extracellular and intracellular barriers by altering their
physico-chemical properties in response to a variety of
extracellular and intracellular stimuli. Multifunctional
nanotheranostics based on responsive polymers integrating
both imaging probes and nucleic acids have also been
developed for disease diagnosis and targeted gene delivery.
Currently developed systems were shown to be able to
protect the loaded nucleic acids from external effects like
nuclease degradation. However, nucleic acids electrostat-
ically complexed with polymers are faced with difficulties
in efficient release at target sites due to strong electrostatic
interactions and toxicity problems caused by excess
cationic charge. This situation was partly resolved by the
attachment of nucleic acid to the polymer based system
through cleavable bonds responsive to redox potential.
The cleavable disulfide bonds reduced by the higher
glutathione concentrations in cytoplasm are commonly
used to facilitate the cytoplasmic siRNA release and
reduce toxicity. However, the same strategy cannot
work for pDNA since it needs to penetrate and release
in the nucleus to show activity. Although this makes the
cleavable bond strategy specific to the type of nucleic
acid and non-universal, it still helps to decrease the toxic
effect of the cationic complexes. In addition, the use of
cleavable bonds may cause premature dissociation and
release during the blood circulation which ends up with
the nucleic acid degradation.
Most of the proposed systems in the literature involve
hydrophilic moieties, such as PEG, to increase the stability
and stealth properties. Although these components enhance
stability and blood circulation times, their hydrophilic
nature inhibits the cellular uptake. This situation was
eliminated by using some ligands or receptors to provide
both cell targeting and enhanced cellular uptake. As a better
alternative, amphiphilic temperature or pH-responsive
polymers with micellization properties were used in
combination with ligands or receptors to provide both
stability and stealth properties accompanied with effi-
cient cellular uptake. The current studies also strongly
addressed the problem of endosomal escape by using
pH-responsive polymers or linkers. The problem with
pH-responsive linkers is their specificity to the used
chemistry and possible risk of premature dissociation.
The pH-responsive polymers provide endosomal escape
through proton sponge effect, which was argued that not
all the polymers with buffering capacity are applicable.
Also, the cationic nature of these pH-responsive poly-
mers involve possible toxicity issues. Beyond these
problems, the gene therapy mainly suffers from the lack
of safe and efficient delivery systems for therapeutic
nucleic acids in the stage of clinical trials. The potential
toxicity and systemic clearance of developed systems
have not been fully understood. Other than the acute
toxicity and inflammatory response, the long-term phar-
macological and toxicological effects of the developed
systems and materials should be evaluated as well.
Therefore, better characterization tools and in vivo animal
models should be addressed for major safety evaluations
before translation to clinical stage. In addition, the un-
modified nucleic acids causing off-targeting effect and
possible triggering of the innate immune system should
also be considered before clinical application. Although
chemical modifications may avoid off-targeting effects
and reduce immunostimulatory activity, the global gene
expression and immune response are still significantly
influenced by the used material. Therefore, polymeric
materials used in the development of multifunctional
gene delivery systems have to be biocompatible, bio-
degradable and nonimmunogenic. Moreover, the major
relationships between the material’s physicochemical
properties and its cytotoxicity, cellular internalization,
and intracellular trafficking can be reevaluated.
The complex process of nucleic acid delivery makes
it difficult to clearly identify all the factors affecting
successful gene therapy. Despite the significant advances
in the design and generation of novel stimuli-responsive
materials, there is a continuous need to do the basic
research addressing the structural effects of respon-
sive polymers, such as molecular weight, polydispersity,
charge density, hydrophilicity/hydrophobicity, functionality
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and so forth, on the nucleic acid condensation capability,
stability, physicochemical properties, and cellular interac-
tions of the formed delivery systems. These properties of
polymers can be controlled by applying novel synthetic
methodologies such as controlled radical polymerization,
click chemistry, or combination of various methodologies,
to achieve well-defined structures. In particular, the
optimization of controlled polymerization techniques
allows for the synthesis of novel copolymers with well-
defined architectures, reproducible molecular weights, low
polydispersities, and end-group functionality. In addition,
the straightforward conjugation chemistries allow the facile
incorporation of responsive groups (or attachment of
drugs) into polymer structures. The combination of
controlled polymerization and conjugation methods
enables the development of well-defined and tunable
structures through copolymer self-assembly. Therefore,
advances in stimuli-responsive copolymer assemblies
obtained by polymer synthesis and macromolecular design
strategies will be the solution to developing an ideal
delivery system.
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